Although apnea is a common neonatal problem, its impact on the cerebral circulation is unknown. CBFV was measured with the transcutaneous Doppler technique at the anterior fontanel. Determination of area under the velocity curve (A.U.V.C.) was utilized to quantitate CBFV. The objective of this study was to examine the effects of apnea on CBFV. Ten infants <1500 gm were studied at rest and during apnea. Apnea was defined as cessation of respiration for >15 sec. In each patient, the effects were similar. Initially, a decrease in diastolic flow velocity (DFV) occurred as the heart rate decreased. With marked bradycardia (heart rate (80). a decrease in systolic flow velocity (SFV) developed and a further decrease in DFV was noted. SFV and DFV returned to baseline within sec. following the onset of spontaneous respiration, but with a delay in those requiring resuscitation. Simultaneous intra-arterial blood pressure ( Med. 309:204, 1983).
The data show that apnea with bradycardia results in a progressive decrease in CBFV, most severe with heart rate <80. It seems possible that such repeated decreases in CBFV could cause or exacerbate cerebral hypoxic-ischemic injury. Louis Child. Hosp., Depts. Peds., Neurol., St. Louis.
Utilizing the transcutaneous Doppler technique at the anterior fontanel, we have demonstrated previously the nearly constant association of fluc. CBFV and the subsequent development of IVH in preterm infants with RDS (New Engl . J. Med. 309:204, 1983 ).
Paralysis with pancuronium was shown to convert the fluc. CBFV to a stable CBFV pattern. The objectives of this prospective, randomized study in intubated preterm infants with RDS and fluc. CBFV was to examine the effects of pancuronium on the occurrence of IVH. Seventeen infants <I500 gm have been studied; 9 infants were paralyzed within 24 h of birth and 8 were not paralyzed (controls). Paralysis was maintained for approximately 48 h.
All 8 control infants developed large IVH within 48 h, consistent with our previous observations. In contrast, none of the 9 paralyzed infants developed IVH while on pancuronium. However, 4 infants developed small IVH from 1-9 days after cessation of paralysis. Even if t h e a t t e r 4 infants are included in the statistical analysis, the difference in incidence of IVH in the two patient groups remains significant (p <0.05).
Thus, this study of muscle paralysis in ventilated infants with fluc. CBFV, who are at extreme risk for development of IVH, demonstrates a significant reduction in incidence (as well as severity) of the IVH in the paralyzed patients. T doses in current clinical use were derived without pharmacokinetic studies in infants. We developed a chemically-specific assay for T and measured its pharmacokinetics following pulse and infusion doses (n=12) and its concentration changes during infusion doses in 8 infants. T half-life correlated with urine output from 0.40-2.35 ml/kg/hr (R=0.77). The overall T beta ( 8 ) averaged 0.0033I0.0023 (ISD, n=12) with distribution volume of 1495+630 ml/kg in 6 infants who received single pulse doses. T infusions between 1.0 and 5.8 mg/kg/hr for 10.8-101.5 hrs produced progressive accumulation of T in all patients. The highest infant T concentration (16.4 ug/ml) approached lethal, cardiotoxic levels in animals (21.8 Ug/ml). Current T infusion doses exceed neonatal clearance of T, even with normal urine output. Using the infants' average 8 and Vds, the T infusion dose to maintain a constant plasma T concentration can be ~stimated as 0 . 2 mg/kg/hr for each 1.0 mg/kg loading dose. Current infusion doses of T are much higher than those predicted by neonatal T pharmacokinetics, may account for accumulation of T in neonates, and may lead to adverse effects. Oliguria during T infusion may require further decreases in dose. Intermittent pulse doses of T may be safer than continuous infusions. 
TOLAZOLINE (T) DOSE ADJUSTMENTS

t i o o f PC t o t o t a l e x t r g c t e d p h o s p h o l i p i d s e c r e t e d i n t o t h e medium
by oxygen exposed c e l l s was a l s o decreased by 30%. Type I 1 c e l l s were a l s o i s o l a t e d f r o m newborn r a t s exposed t o 100% oxygen f o r 6 days. Y i e l d s o f c e l l s f r o m oxygen t r e a t e d animgls was about 75% o f room a i g c o n t r o l s (approximately 6.6 x 10 c e l l s p e r r a t versus 8.6 x 10 c e l l s p e r r a t ) . These s t u d i e s i n d i c a t e t h a t f u n c t i o n a l t y p e I 1 c e l l s can be i s o l a t e d f r o m oxygen exposed newborn r a t s and t h a t s u r f a c t a n t s y n t h e s i s i s decreased by 24 hours o f oxygen exposure. Supported by USPHS Grant HD 17785. (Spon. by John C. S i n c l a i r ) , McYaster U n i v e r s i t y , Depts. o f In sheep, FBM occur intermittently, and only during low P e d i a t r i c s and P s y c h i a t r y , Hamilton, O n t a r i o voltage, fast electrocortical activity; at birth, when PGE conPre-term i n f a n t s <72 h r s o l d , o f b i r t h -w e i g h t 750-14999, who centrations ([PGE I ) fall, breathing becomes continuous. ~Z c l owere n o t b e i n g v e n t i l a t e d , were assigned randomly t o be nursed on fenamate (Mec), ~'PG synthetase inhibitor, decreases [PGE I and
REGULATION OF FETAL BREATHING MOVEMENTS (FBM
OAM o r conventional m a t t r e s s (C). To demonstrate a r e d u c t i o n
stimulates FBM to occur almost continuously, even during iigh from 50% t o 25% i n t h e p r o p o r t i o n o f i n f a n t s w i t h > 1 day o f >5 voltage, slow electrocortical activity (HVSA). To investigate episodes o f apnea and b r a d y c a r d i a (AB) r e q u i r e d a iiinimum sample the role of PGE in regulating FBM, we studied 6 fetal sheep at s i z e o f 50 p e r qroup (a-.05, 8-0.2 ). E n t r y was s t r a t i f i e d i n 127-134d gestatzon. We infused Mec for 34 hr; after 12 hr we 2509 b i r t h -w e i g h t groups and each study concluded a f t e r 14 days added incremental doses of PGE , each for 2-3 hr. These caused o r a t GAz34 weeks. T h e o p h y l l i n e was q i v e n o n l y i f A8s exceeded no changes in pH, Pco , Po , o? blood pressure. Mec decreased 10 p e r day. Episodes o f A8 (apnea >15 secs, + h e a r t -r a t e 4 0 o r IPGE I to neonatal 1e;els 2nd increased the incidence of FBM, r e q u i r i n g s t i m u l a t i o n ) were recorded by nurses and t h r e e 6-hour espezially during HVSA. Effects of PGE on EBM during Mec are: c a r d i o -r e s p i r o g r a p h r e c o r d i n g s were made. Growth and neuro~eclofenimate (0.45-1.5 mg/kg/hr) behavioural development were measured. B i r t h -w e i q h t , g e s t a t i o n a l Incidence of FBM Prior to PGE, (ng/kg/min) age and s e v e r i t y o f i n i t i a l RDS were s i m i l a r i n each qroup. The Infusions O 9 ' 18 36 90 average number o f ABs p e r day i n each o f 3 i n i t i a l 5-day epochs % of time 29 67 52 42 34 16 was s i m i l a r , as were t h e p r o p o r t i o n s r e q u i r i n a t h e o p h y l l i n e % of time in HVSA 2 57 30 17 7 2 (OAM=17/50, C=17/63) o r IPPV(OAM=3, C = l ) , o r having a s i n a l e day The relationship between PGE dose and FBM can be described by a w i t h >5 ABs (OAM=53%, C=56%). There was no d i f f e r e n c e i n t h e curvilinear equation (r =0.6', p <0.001). At a dose of 36 ng/kg/ i n c i d e n c e of NEC o r IVH and no i n f a n t d i e d . O s c i l l a t i n p a i r 
